Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11

Patients with cerebrovascular disease (CeVD) have been shown to benefit from lipid-lowering therapies, but guideline-recommended levels of low-density lipoprotein cholesterol (LDL-C) are often not attained with statin treatment alone. The ORION-9, ORION-10, and ORION-11 trials evaluated the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Koenig, Wolfgang, Ray, Kausik K., Landmesser, Ulf, Leiter, Lawrence A., Schwartz, Gregory G., Wright, R. Scott, Conde, Lorena Garcia, Han, Jackie, Raal, Frederick J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209488/
https://www.ncbi.nlm.nih.gov/pubmed/37252442
http://dx.doi.org/10.1016/j.ajpc.2023.100503

Ejemplares similares

Ejemplares similares